WORLD-FIRST EXPERIMENTAL CANCER TREATMENT PAVES WAY FOR CLINICAL TRIAL
Nature Medicine has published a peer reviewed paper detailing the experimental glioblastoma cancer treatment developed by Professor Georgina Long AO, Medical Director of Melanoma Institute Australia, paving the way for a clinical trial to be conducted by researchers at The Brain Cancer Centre in Melbourne.
Professor Long used her expertise in immunotherapy and drew on melanoma science to devise, lead and administer the treatment, the first documented use of neoadjuvant triple immunotherapy in glioblastoma.
LATEST NEWS
Our thanks to Prof Richard Scolyer AO
Prof Richard Scolyer AO has announced that he has decided to step down from his role as Co-Medical Director of Melanoma Institute Australia. Richard has been in this role since January 2017.
Marching for a cure: Aussies urged to take steps to help save lives from melanoma
Melanoma March events are held across Australia during March to raise awareness about melanoma and help save lives.
SunSafe Student Ambassador Program 2024 winners announced
Sacred Heart College, Hobart has been announced winner of the 2024 SunSafe Student Ambassador Program competition, with Lucas Heights Community School, Sydney & St Paul's College, Walla Walla joint runners-up.
Outstanding efforts by Community Fundraisers all over Australia
From zumba events to kilt runs and motorcycle rides, read more about the Australia-wide efforts of our passionate community fundraisers, and their supporters, all contributing to not only support our life-saving research, but also raise awareness about melanoma and its prevention.
MIA’s ground-breaking work recognised with two Cancer NSW Awards
We are proud to announce that the ground-breaking work of the MIA team has been recognised with two prestigious 2024 NSW Premier’s Awards for Outstanding Cancer Research.
Be part of research study on genetic information and testing
Patients, and families of patients, impacted by advanced melanoma are invited to participate in an online interview to explore their views, experiences, and needs related to genetic information, support and testing.
MIA’s MISSION
ZERO DEATHS FROM MELANOMA
MIA will achieve its mission through 3 pillars of action: Research, Clinical Care & Education.
MIA conducts its research under 4 themes: Prevention, Risk & Clinical Detection – Early Melanoma – Advanced Melanoma – Supportive Care & Survivorship.
1300
It is estimated 1300 Australians will die from melanoma this year
30 mins
1 Australian is diagnosed with melanoma every 30 minutes
90%
If caught early 90% of melanomas can be cured by surgery
Age 20-39
Melanoma is the most common cancer affecting Australians aged 20 to 39
